US Panel Backs Trendy Peptides Despite Safety Questions

A US regulatory panel has endorsed trendy peptides despite acknowledging weak evidence supporting their safety profile. The decision reflects growing interest in peptide-based treatments and supplements among consumers seeking health and wellness solutions. Experts have raised concerns about the limited research backing these products, yet the panel's approval signals confidence in their potential benefits.